QUSVM
Qiming U.S. Ventures Management Portfolio holdings
AUM
$23.6M
This Quarter Return
+77.56%
1 Year Return
-18.39%
3 Year Return
+715.34%
5 Year Return
–
10 Year Return
–
AUM
$109M
AUM Growth
+$109M
(+45%)
Cap. Flow
-$42.3M
Cap. Flow
% of AUM
-38.76%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
Korro Bio
KRRO
|
$17.6M |
Top Sells
| 1 |
Tourmaline Bio
TRML
|
$60M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICVX
1
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $55.3M | 50.66% | 3,510,228 | – | – |
|
|
2
Korro Bio
KRRO
$217M
| $17.6M | 16.15% | +368,085 | New | +$17.6M |
|
|
3
Tourmaline Bio
TRML
$601M
| $16.8M | 15.38% | 641,691 -2,290,915 | -78% | -$60M |
|
4
HilleVax
HLVX
$105M
| $8.97M | 8.21% | 558,923 | – | – |
|
5
Jasper Therapeutics
JSPR
$45.5M
| $6.72M | 6.16% | 8,519,648 | – | – |
|
6
Ventyx Biosciences
VTYX
$171M
| $1.7M | 1.55% | 686,370 | – | – |
|
|
ELEV
7
DELISTED
Elevation Oncology
ELEV
| $1.27M | 1.17% | 2,370,142 | – | – |
|
8
Kezar Life Sciences
KZR
$28.9M
| $785K | 0.72% | 828,711 | – | – |
|